Cancer cells avoid programmed cell death by producing Mcl-1, Bcl-xL, and Bcl-2, and genetic mutations cause alterations in pro-apoptotic control, such as TP53 (Akl et al., 2014[1]). Here, TP53 is linked to cancer.